# Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge

> **NCT05548205** · NA · RECRUITING · sponsor: **NYU Langone Health** · enrollment: 150 (estimated)

## Conditions studied

- Diabetes

## Interventions

- **DEVICE:** Continuous Glucose Monitor
- **DEVICE:** Blood Glucose Monitor

## Key facts

- **NCT ID:** NCT05548205
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-16
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-04-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05548205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05548205, "Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05548205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*